Press Releases

The following are official statements issued by UsAgainstAlzheimer’s in response to major national policy actions, industry events, breaking news, or organizational achievements. Please see the UsAgainstAlzheimer’s press kit page for additional information. For media requests, please contact Chantez Bailey at [email protected].

  • July 17, 2023

    New Donanemab Data Demonstrates Momentum Toward Choice of Treatments for Alzheimer’s Patients

    Research shows no clinical progression for nearly half of early-stage patients at...

    Read more
  • July 06, 2023

    UsAgainstAlzheimer’s Applauds FDA Approval of Leqembi for Treatment of Early-Stage Alzheimer’s

    Medicare must now provide coverage for patients.

    Read more
  • June 13, 2023

    UsAgainstAlzheimer's Applauds Unanimous Leqembi Endorsement by FDA Advisory Committee and Encourages Speedy Access for Patients

    The Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs...

    Read more
  • June 01, 2023

    UsAgainstAlzheimer’s Statement on CMS Announcement of Registry for Access to FDA-Approved Alzheimer’s Treatments

    UsAgainstAlzheimer’s greeted the Centers for Medicare & Medicaid Services (CMS) potential approach...

    Read more
  • May 23, 2023

    New Poll: Huge Majorities Want Medicare to Cover Cost of Alzheimer’s Drugs

    Americans want Congress and the president to step in if CMS doesn’t...

    Read more
  • May 11, 2023

    Patients and Caregivers Now Have Option for Treating Alzheimer’s-Related Agitation

    Alzheimer’s patients, caregivers, and advocates are applauding the decision by the Food...

    Read more
  • May 03, 2023

    More Promising News for People Living with Alzheimer's

    Patients Cheer Phase 3 clinical trials showing new drug slows decline compared...

    Read more
  • April 24, 2023

    Brain Health Academy Enrollment is Now Open, First Session Launches May 17

    Free continuing education program for health and wellness professionals adds six new...

    Read more
  • April 14, 2023

    UsAgainstAlzheimer’s Letter to Becerra: Your Inaccurate Statements to the Senate Must Be Corrected

    In a letter sent today to Health and Human Services Secretary Xavier...

    Read more

Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer's. This report found that deep social inequities exist in countries highly impacted by Alzheimer's among Latinos and Blacks.

Read Report